Clinical Trials Insight: 700028704
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2009
At a glance
- Drugs Perifosine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 Jun 2009 Primary endpoint 'Locoregional control' has not been met.
- 08 Jun 2009 Status changed from active, no longer recruiting to completed; results reported in a AEterna Zentaris media release.
- 22 Nov 2007 New trial record.